Literature DB >> 2359146

Herpes simplex virus type I infection of the CNS induces major histocompatibility complex antigen expression on rat microglia.

D L Weinstein1, D G Walker, H Akiyama, P L McGeer.   

Abstract

Rats were infected with herpes simplex virus type I (HSV-1) by corneal scarification. The spread of virus in the brain, the infiltration of leucocytes into infected areas, and the expression of major histocompatibility complex (MHC) glycoproteins by brain cells were assessed as a function of time by immunohistochemistry. Virus moved along neuronal pathways, achieving widespread distribution in the brain by days 8-10 when the illness appeared most severe. Granulocytes, T-lymphocytes, and monocytes infiltrated the tissue matrix at sites of infection. Microglial cells were induced to express MHC class I and class II glycoproteins. Reactive microglia near the sites of infection most vigorously expressed such glycoproteins. At the peak of the infection they were detectable on microglia throughout the brain, including areas apparently separated from active infection. Evidence of viral antigens, as well as microglial MHC expression, had largely disappeared by day 30. Neurons, astrocytes, and oligodendroglial cells failed to express MHC antigens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2359146     DOI: 10.1002/jnr.490260107

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  22 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia.

Authors:  T Morioka; A N Kalehua; W J Streit
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia.

Authors:  T Valyi-Nagy; S Deshmane; A Dillner; N W Fraser
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Lesion of the rat entorhinal cortex leads to a rapid microglial reaction in the dentate gyrus. A light and electron microscopical study.

Authors:  J Gehrmann; S W Schoen; G W Kreutzberg
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Authors:  Chandra M Menendez; Jeremy K Jinkins; Daniel J J Carr
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

6.  Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.

Authors:  Z Bi; M Barna; T Komatsu; C S Reiss
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

Review 7.  Domoic acid-induced neurotoxicity in the hippocampus of adult rats.

Authors:  Ananth Chandrasekaran; Gopalakrishnakone Ponnambalam; Charanjit Kaur
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

8.  Borna disease: association with a maturation defect in the cellular immune response.

Authors:  K M Carbone; S W Park; S A Rubin; R W Waltrip; G B Vogelsang
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Immunophenotypic features of epiplexus cells and their response to interferon gamma injected intraperitoneally in postnatal rats.

Authors:  J Lu; C Kaur; E A Ling
Journal:  J Anat       Date:  1994-08       Impact factor: 2.610

10.  Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response.

Authors:  G A Lewandowski; D Lo; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.